Brain

Antioxidant has potential in the Alzheimer's fight, UGA researchers find

Athens, Ga. – When you cut an apple and leave it out, it turns brown. Squeeze the apple with lemon juice, an antioxidant, and the process slows down.

Simply put, that same "browning" process—known as oxidative stress—happens in the brain as Alzheimer's disease sets in. The underlying cause is believed to be improper processing of a protein associated with the creation of free radicals that cause oxidative stress.

Biochemical signature predicts progression to Alzheimer's disease

A study led by Research Professor Matej Orešič from VTT Technical Research Centre of Finland suggests that Alzheimer's disease is preceded by a molecular signature indicative of hypoxia and up-regulated pentose phosphate pathway. This indicator can be analysed as a simple biochemical assay from a serum sample months or even years before the first symptoms of the disease occur.

A novel mechanism regulating stress is identified

BOSTON (December 13, 2011, 5:00 pm ET) — Neuroscience researchers from Tufts have demonstrated, for the first time, that the physiological response to stress depends on neurosteroids acting on specific receptors in the brain, and they have been able to block that response in mice. This breakthrough suggests that these critical receptors may be drug therapy targets for control of the stress-response pathway. This finding may pave the way for new approaches to manage a wide range of neurological disorders involving stress.

Dodging the cognitive hit of early-life seizures

About half of newborns who have seizures go on to have long-term intellectual and memory deficits and cognitive disorders such as autism, but why this occurs has been unknown. In the December 14 Journal of Neuroscience, researchers at Children's Hospital Boston detail how early-life seizures disrupt normal brain development, and show in a rat model that it might be possible to reverse this pathology by giving certain drugs soon after the seizure.

Tireless research reveals secrets of the 'sleep hormone'

Scientists provide potential explanation for mechanisms of associative memory

Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories. The findings, published today [13 Dec] in the Journal of Neuroscience, may also provide a potential explanation for the loss of memory associated with Alzheimer's.

High levels of tau protein linked to poor recovery after brain injury

High levels of tau protein in fluid bathing the brain are linked to poor recovery after head trauma, according to a study from Washington University School of Medicine in St. Louis and the Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico in Milan, Italy.

Was Darwin wrong about emotions?

Contrary to what many psychological scientists think, people do not all have the same set of biologically "basic" emotions, and those emotions are not automatically expressed on the faces of those around us, according to the author of a new article published in Current Directions in Psychological Science, a journal published by the Association for Psychological Science. This means a recent move to train security workers to recognize "basic" emotions from expressions might be misguided.

Reprogramming brain cells important first step for new Parkinson's therapy

PHILADELPHIA - In efforts to find new treatments for Parkinson's Disease (PD), researchers from the Perelman School of Medicine at the University of Pennsylvania have directly reprogrammed astrocytes, the most plentiful cell type in the central nervous system, into dopamine-producing neurons. PD is marked by the degeneration of dopaminergic neurons in the midbrain. Dopamine is a brain chemical important in behavior and cognition, voluntary movement, sleep, mood, attention, and memory and learning.

Study explores men's ability to manage fear in ways that allow them to exhibit confidence

WASHINGTON, DC, December 13, 2011 — An Indiana University of Pennsylvania sociologist's study of mixed martial arts competitors found that these men have unique ways of managing fear that actually allow them to exhibit confidence.

Immunity against the cold

Throughout the interior spaces of humans and other warm-blooded creatures is a special type of tissue known as brown fat, which may hold the secret to diets and weight-loss programs of the future.

Unlike ordinary "white" fat, in which the body stores excess calories, brown fat can burn calories to heat up the body. It's one of the things that helps keep wild critters warm on cold nights.

Artificially enhanced athletes

CHICAGO --- Superstar swimmers and certain comic book superheroes have something unusual in common--when they wear special suits, they gain phenomenal abilities. A first-of-its-kind study from Northwestern Medicine highlights how now-banned technical swimsuits artificially enhanced athlete performance in 2009.

Widespread brain atrophy detected in Parkinson's disease with newly developed structural pattern

PHILADELPHIA – Atrophy in the hippocampus, the region of the brain known for memory formation and storage, is evident in Parkinson's disease (PD) patients with cognitive impairment, including early decline known as mild cognitive impairment (MCI), according to a study by researchers in the Perelman School of Medicine at the University of Pennsylvania. The study is published in the December issue of the Archives of Neurology, one of the JAMA/Archives journals.

Bigger, scarier weapons help spiders get the girl

DURHAM, N.C. – If you're a red-headed guy with eight bulging eyes and a unibrow, size does indeed matter for getting the girl.

More specifically, the bigger a male jumping spider's weapons appear to be, the more likely his rival will slink away without a fight, leaving the bigger guy a clear path to the waiting female.

Test for Alzheimer's disease predicts cognitive decline in Parkinson's disease

PHILADELPHIA – A method of classifying brain atrophy patterns in Alzheimer's disease patients using MRIs can also detect cognitive decline in Parkinson's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Researchers also found that higher baseline Alzheimer's patterns of atrophy predicted long-term cognitive decline in cognitively normal Parkinson's patients. The study is published online in Brain.